Is a DNA Test During Pregnancy Safe?

Learn if NIPT (cell-free DNA screening) is safe for you and your baby. Compare non-invasive vs invasive tests, accuracy, and how to order a prenatal panel.

A DNA test during pregnancy is generally safe for both mother and baby when performed as a non-invasive prenatal screening (NIPT) using cell-free DNA. This blood test analyzes fetal DNA fragments circulating in the mother’s bloodstream, posing no risk of miscarriage or harm. Unlike invasive procedures such as chorionic villus sampling (CVS) or amniocentesis, NIPT requires only a simple blood draw, making it a low-risk option for expectant parents in the United States. For 2026, updated guidelines continue to support NIPT as a first-line screening for common chromosomal conditions, with accuracy rates above 99% for trisomies 21, 18, and 13 when fetal fraction is adequate.

What Is Non-Invasive Prenatal Testing (NIPT)?

NIPT, also called non-invasive prenatal testing, is a screening method that analyzes cell-free DNA (cfDNA) from the placenta that appears in the mother’s blood. It can be performed as early as 10 weeks of gestation and does not require any needles entering the uterus. The test screens for aneuploidies (extra or missing chromosomes) and, in some expanded panels, can also detect sex chromosome abnormalities and microdeletions. A key safety advantage is that NIPT carries zero risk of miscarriage, unlike invasive diagnostic tests.

How Does NIPT Differ From Invasive Tests?

Invasive prenatal tests like chorionic villus sampling (CVS) and amniocentesis collect fetal tissue or fluid directly from the uterus. While these offer definitive diagnosis, they carry a small risk of miscarriage (approximately 0.1–0.3% for amniocentesis). In contrast, NIPT is a screening test—it indicates increased or decreased risk but does not diagnose. However, its safety profile makes it the preferred first step for most pregnant people. A positive NIPT result should be followed by a diagnostic test (e.g., amniocentesis) and a consultation with a genetic counselor.

Safety of DNA Testing During Pregnancy

DNA testing via NIPT is considered safe because it is non-invasive. The blood draw is routine, similar to other prenatal blood work. There is no contact with the amniotic sac or placenta, so infection, bleeding, or miscarriage are not risks. The main limitation is a potential false positive or false negative result, which can cause anxiety but does not physically harm the pregnancy. Occasionally, a low fetal fraction—the percentage of cell-free DNA from the placenta—may lead to a failed test, requiring a redraw. This is not dangerous but can delay results.

When Is DNA Testing Not Recommended?

NIPT is not recommended for women with multiple gestations (twins/triplets) unless the test is validated for that scenario, and it is not a substitute for carrier screening or first-trimester screening (e.g., nuchal translucency ultrasound). If you need to confirm paternity, a prenatal paternity test can be done non-invasively using cfDNA, but it is separate from medical NIPT. Always discuss your medical history with a healthcare provider or genetic counselor before ordering.

Comparison of Prenatal DNA Tests: Safety & Accuracy

Test Type	Risk to Pregnancy	Accuracy	Timing
NIPT (cell-free DNA)	None (blood draw only)	≥99% for trisomy 21	From 10 weeks
Chorionic Villus Sampling (CVS)	~0.2% miscarriage risk	~99% diagnostic	10–13 weeks
Amniocentesis	~0.1–0.3% miscarriage risk	~99% diagnostic	15–20 weeks
Quad Screen (maternal serum)	None (blood draw)	~80–85% for Down syndrome	15–20 weeks

Key Benefits of NIPT (Non-Invasive Prenatal Testing)

Zero miscarriage risk – no needles enter the uterus.
Early results – can be done from 10 weeks, with results in 7–10 days.
High accuracy – >99% for common trisomies (21, 18, 13).
Can screen for sex chromosome anomalies – e.g., Turner syndrome, Klinefelter syndrome.
Optional expanded panels – include microdeletions like 22q11.2 (DiGeorge).
Can include fetal sex determination – if desired.

Frequently Asked Questions About DNA Test Safety in Pregnancy

Can NIPT cause a miscarriage?

No. NIPT is a blood test from the mother’s arm and does not touch the uterus, so it cannot cause a miscarriage.

How accurate is NIPT compared to amniocentesis?

NIPT is a screening test with >99% sensitivity for trisomy 21, but it is not diagnostic. Amniocentesis is diagnostic and nearly 100% accurate, but carries a small procedure risk. A positive NIPT should be confirmed with amniocentesis or CVS.

When should I take a DNA test during pregnancy?

NIPT is typically offered after 10 weeks. It can be part of first-trimester screening or integrated screening. Some women choose it after a positive quad screen or if they have risk factors like advanced maternal age.

Is prenatal paternity testing safe?

Non-invasive prenatal paternity testing using cell-free DNA is safe for the pregnancy because it only requires a blood sample from the mother and a cheek swab from the alleged father. There is no risk of miscarriage.

If you are considering a DNA test during pregnancy, NIPT offers a safe, accurate, and early screening option for chromosomal conditions. To learn more about the comprehensive panels available—including carrier screening for conditions like SMA, fragile X, and cystic fibrosis—you can order a prenatal screening panel online and receive results quickly, typically within 7–10 business days. Always discuss your results with a genetic counselor or healthcare provider.